Please assess the completion status of the following clinical trial:

Trial Title: Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* patients with PMR, diagnosed according to the criteria of Bird et al~Exclusion Criteria:~* patients with arthritis~* patients with giant cell arteritis~* patients with Parkinson's disease~* patients with hypothyroidism~* patients with scapulohumeral periarthritis~* patients with fibromyalgia~* patients unable to cooperate

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).